TCRT
Alaunos Therapeutics Inc
NASDAQ: TCRT · HEALTHCARE · BIOTECHNOLOGY
$2.55
-0.39% today
Updated 2026-04-30
Market cap
$6.16M
P/E ratio
—
P/S ratio
1,231.94x
EPS (TTM)
$-2.20
Dividend yield
—
52W range
$2 – $5
Volume
0.0M
Alaunos Therapeutics Inc (TCRT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.42M | $-21.65M | $-23.52M | $-12.29M | $-19.69M | $-38.84M | $-78.83M | $-59.51M | $-36.65M | $-10000.00 | $-58.33M | $-54.67M | $-49.46M | $-40.85M | $-57.01M | $-61.47M | $-29.23M | $-30.14M | $-4.97M | $-2.87M |
| Capital expenditures | $354300.00 | $738115.00 | $132000.00 | $11000.00 | $186000.00 | $1.16M | $1.56M | $132000.00 | $193000.00 | $412000.00 | $551000.00 | $737000.00 | $459000.00 | $284000.00 | $9.78M | $3.32M | $216000.00 | $197000.00 | $0.00 | $98000.00 |
| Depreciation | $173920.00 | $433353.00 | $388000.00 | $330000.00 | $188000.00 | $268000.00 | $658000.00 | $738000.00 | $462000.00 | $357000.00 | $290000.00 | $369000.00 | $575000.00 | $629000.00 | $1.13M | $2.60M | $2.76M | $2.31M | $2000.00 | — |
| Stock-based comp | $2.88M | — | $1.60M | $2.18M | $3.64M | $2.76M | $4.88M | $3.51M | $4.74M | $8.00M | $8.45M | $8.45M | $7.53M | $7.34M | $6.83M | $10.77M | $3.53M | $2.80M | $435000.00 | $414000.00 |
| Free cash flow | $-14.78M | $-22.39M | $-23.65M | $-12.30M | $-19.88M | $-39.99M | $-80.39M | $-59.64M | $-36.84M | $-422000.00 | $-58.88M | $-55.41M | $-49.92M | $-41.14M | $-66.79M | $-64.79M | $-29.45M | $-30.34M | $-4.97M | $-2.97M |
| Investing cash flow | $-1.91M | $817049.00 | $-131000.00 | $-11000.00 | $-186000.00 | $-1.16M | $-1.56M | $-131000.00 | $-193000.00 | $-412000.00 | $-551000.00 | $-737000.00 | $-459000.00 | $-284000.00 | $-9.78M | $-3.32M | $-193000.00 | $1.35M | — | — |
| Financing cash flow | $34.31M | $29.01M | — | $49.77M | $31.43M | $84.31M | $48.98M | $54.54M | $11.44M | $98.34M | $-788000.00 | $45.30M | $40.31M | $59.15M | $102.12M | $25.78M | $6.37M | $-18.14M | $0.00 | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | $7.12M | — | $17.00M | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $-23.06M | — | — | — |